can anyone expand on this comment from the Hambrecht report.
"two patients in 40 mg non-study eye had changes of +5.6 lines"
Did they only pick one eye to study?
I would have to say 5.6 lines is pretty damn good when your talking 2 out of 6 patients. If they can get that kind of results in that short of a time span prolonged usage may not be needed. It would certainly be worth a try for every patient to see if it works even on a short term basis.
Randy
Points made in new 1/12/05 Hambrecht report:
believe GENR is significantly undervalued
40 mg dose more efficacious than 10 mg (fancy that !)
patients with two affected eyes had benefit in both eyes
two patients in 40 mg non-study eye had changes of +5.6 lines
expect completion of enrollment all ph 2 trials in Q105
affirmation of GENR solid relationship with FDA to increase partnering potential
Market Data 
Markets 
AI
